日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The role of immunotherapy and chemotherapy combinations in TKI-resistant EGFR-mutant non-small cell lung cancer: insights from real-world evidence

免疫疗法和化疗联合治疗在TKI耐药的EGFR突变型非小细胞肺癌中的作用:来自真实世界证据的启示

Chen, I-Ting; Huang, Hsu-Ching; Chiang, Chi-Lu; Shen, Chia-I; Tseng, Yen-Han; Liao, Ying-Ting; Chen, Yuh-Min; Luo, Yung-Hung

Real-world therapeutic strategies and survival outcomes in advanced HER2 -mutant non-small cell lung cancer

晚期 HER2 突变型非小细胞肺癌的真实世界治疗策略和生存结果

Sun, Ruei-Lin; Liao, Pei-Ya; Liao, Ying-Ting; Yeh, Yi-Chen; Chiang, Chi-Lu; Chen, Yuh-Min; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Huang, Hsu-Ching; Shen, Chia-I; Tseng, Yen-Han; Huang, Yen-Hsiang; Luo, Yung-Hung; Yang, Tsung-Ying

First-line immune checkpoint inhibitors plus chemotherapy in Taiwanese patients with extensive-stage small-cell lung cancer

一线免疫检查点抑制剂联合化疗治疗台湾广泛期小细胞肺癌患者

Liao, Ying-Ting; Sun, Ruei-Lin; Huang, Hsu-Ching; Shen, Chia-I; Tseng, Yen-Han; Luo, Yung-Hung; Chen, Yuh-Min; Chiang, Chi-Lu

Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignancies

在晚期非小细胞肺癌和其他恶性肿瘤患者中,sasanlimab 替代给药方案的药代动力学、安全性和有效性研究

Penkov, Konstantin; Bondarenko, Igor; Saenko, Daria Viktorovna; Kulyaba, Yaroslav; Guo, Jun; Gong, Yi; Yamamoto, Noboru; Hotko, Yevhen Stepanovych; Boyko, Vasyl; Fadeeva, Natalya Vladimirovna; Ursol, Grygorii Mykolaiovych; Ahn, Hee Kyung; Kislov, Nikolay Viktorovich; Shen, Chia-I; Davis, Craig; Kowalski, Karey; Michelon, Elisabete; Pavlov, Dmitri; Hirohashi, Tomoko; Cho, Byoung Chul

Immune signatures of patients with advanced non-small-cell lung cancer for efficacy prediction after immunotherapy.

晚期非小细胞肺癌患者的免疫特征用于预测免疫治疗后的疗效

Luo Yung-Hung, Shen Chia-I, Chiang Chi-Lu, Chen Yuh-Min

Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis

EGFR突变型非小细胞肺癌伴软脑膜转移患者奥希替尼治疗结果的预后因素

Chiang, Chi-Lu; Ho, Hsiang-Ling; Yeh, Yi-Chen; Lee, Cheng-Chia; Huang, Hsu-Ching; Shen, Chia-I; Luo, Yung-Hung; Chen, Yuh-Min; Chiu, Chao-Hua; Chou, Teh-Ying

Characteristics, treatment patterns, and clinical outcomes in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertions

携带 EGFR 20 号外显子插入突变的晚期非小细胞肺癌患者的特征、治疗模式和临床结果

Liao, Ying-Ting; Wang, Lei-Chi; Sun, Ruei-Lin; Yeh, Yi-Chen; Huang, Hsu-Ching; Shen, Chia-I; Tseng, Yen-Han; Hsiao, Tsu-Hui; Chao, Heng-Sheng; Luo, Yung-Hung; Chen, Yuh-Min; Chiang, Chi-Lu

Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell-free DNA from non-small-cell lung cancer patients with leptomeningeal metastases

不同平台在检测脑脊液游离DNA中EGFR突变(来自伴有软脑膜转移的非小细胞肺癌患者)方面的疗效

Chiang, Chi-Lu; Ho, Hsiang-Ling; Yeh, Yi-Chen; Lee, Cheng-Chia; Huang, Hsu-Ching; Shen, Chia-I; Luo, Yung-Hung; Chen, Yuh-Min; Chiu, Chao-Hua; Chou, Teh-Ying

State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan

台湾肺癌分子肿瘤学的最新进展

Luo, Yung-Hung; Liang, Kung-Hao; Huang, Hsu-Ching; Shen, Chia-I; Chiang, Chi-Lu; Wang, Mong-Lien; Chiou, Shih-Hwa; Chen, Yuh-Min

Real-world evidence of the intrinsic limitations of PCR-based EGFR mutation assay in non-small cell lung cancer

非小细胞肺癌中基于PCR的EGFR突变检测方法的固有局限性的真实世界证据

Shen, Chia-I; Chiang, Chi-Lu; Shiao, Tsu-Hui; Luo, Yung-Hung; Chao, Heng-Sheng; Huang, Hsu-Ching; Chiu, Chao-Hua